SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017294
Filing Date
2023-05-15
Accepted
2023-05-15 16:05:59
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 838671
2 ex10-1.htm EX-10.1 18052
3 ex10-2.htm EX-10.2 9230
4 ex31-1.htm EX-31.1 16917
5 ex31-2.htm EX-31.2 17591
6 ex32-1.htm EX-32.1 10654
7 ex10-2_001.jpg GRAPHIC 4388
  Complete submission text file 0001493152-23-017294.txt   5599904

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE invo-20230331.xsd EX-101.SCH 49184
9 XBRL CALCULATION FILE invo-20230331_cal.xml EX-101.CAL 58693
10 XBRL DEFINITION FILE invo-20230331_def.xml EX-101.DEF 215986
11 XBRL LABEL FILE invo-20230331_lab.xml EX-101.LAB 408514
12 XBRL PRESENTATION FILE invo-20230331_pre.xml EX-101.PRE 330297
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 731979
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39701 | Film No.: 23922052
SIC: 3841 Surgical & Medical Instruments & Apparatus